Work

Abstract A10: Soluble CD25 and C-reactive protein predict overall survival in melanoma patients receiving anti-CD40 monoclonal antibody CP-870,893 (αCD40) and anti-CTLA4 monoclonal antibody tremelimumab

Year: 2015

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.tumimm14-a10

Authors: Rosemarie Mick, David Bajor, Lee Richman, Robert Vonderheide

Institution: University of Pennsylvania

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2474295058

Cites:

Cited by:

Related to: 10